Daiichi Sankyo Terminates $650 Million Deal With This U.S. Pharma Post author:Sam Post published:August 30, 2017 Post category:BioPharma August 31, 2017By Alex Keown, BioSpace.com Breaking News Staff… Source: BioSpace You Might Also Like Top 20 Life Science Startups to Watch in 2018 January 1, 2018 AstraZeneca PLC Loses $10 Billion in Value as Long-Awaited MYSTIC Trial Disappoints July 26, 2017 PCI Synthesis Wins Big At 2017 Life Science Leader Magazine CMO Leadership Awards March 22, 2017
